Clinical Trial Finds CBD-Dominant Cannabis Extract May Reduce Burning Mouth Syndrome Pain

A new randomized clinical trial suggests that a CBD-dominant, full-spectrum cannabis extract may provide meaningful relief for people living with burning mouth syndrome, a painful and often difficult-to-treat condition.

As first reported by our friends at National NORML, Brazilian researchers found that patients who received plant-derived CBD oil experienced progressive reductions in both the intensity and impact of their pain. Participants also reported improvements in oral health-related quality of life, and researchers observed no adverse events during the study.

For patients who live with persistent oral burning, tingling or discomfort despite having no obvious injury or disease in the mouth, those findings are noteworthy. They also add to the growing body of clinical evidence demonstrating why cannabis and its compounds deserve to be investigated as legitimate therapeutic options.

What Is Burning Mouth Syndrome?

Burning mouth syndrome, commonly abbreviated as BMS, is a chronic condition characterized by a burning, scalding or painful sensation affecting the tongue, lips, gums, palate or other areas of the mouth. Some patients also experience dry mouth, tingling or changes in taste.

What makes the condition especially frustrating is that the pain may occur without a visible lesion or readily identifiable medical cause. Symptoms can persist for months or years and may interfere with eating, sleeping, speaking and a person’s overall quality of life.

Oral burning can sometimes be connected to an underlying issue, including nutritional deficiencies, infections, medication side effects, dry mouth, diabetes or other medical conditions. Primary burning mouth syndrome, however, is diagnosed when clinicians cannot identify an organic cause.

That is why anyone experiencing persistent oral pain should seek a medical or dental evaluation rather than attempting to diagnose the condition independently.

According to National NORML’s original report, burning mouth syndrome affects an estimated two percent of the population and is often poorly controlled by conventional prescription medications.

What Did the CBD Clinical Trial Examine?

The randomized, placebo-controlled clinical trial included 26 patients diagnosed with burning mouth syndrome. Researchers compared a plant-derived, full-spectrum CBD oil with a placebo.

Participants in the CBD group consumed between 10 and 50 milligrams of cannabidiol per day. Researchers assessed their pain and health-related quality of life at the beginning of the study and at several points throughout the trial.

According to the researchers, treatment with the CBD-dominant extract was associated with significant and progressive reductions in pain intensity and the degree to which pain affected patients’ lives.

Improvements reportedly became apparent beginning with the third assessment and were accompanied by better oral health-related quality-of-life scores.

Importantly, the researchers reported no adverse events among the study participants.

The study, titled “Analgesic Effect of Full Spectrum Cannabidiol Oil in Burning Mouth Syndrome: Randomized Single-Blind Placebo Trial,” was published in the journal Oral Surgery, Oral Medicine, Oral Pathology, and Oral Radiology.

Why Are These Findings Important?

Burning mouth syndrome can be stubborn, distressing and difficult to manage. When existing treatments provide inadequate relief, patients and healthcare professionals need additional evidence-based options.

This trial is important because it moves the conversation beyond anecdotal reports. Researchers used a randomized, placebo-controlled design to evaluate a plant-derived CBD formulation in patients diagnosed with a specific chronic pain condition.

The results also build upon earlier cannabis research involving burning mouth syndrome. A 2020 prospective pilot study involving 17 patients found that a full cannabis-plant extract was associated with significant improvement in oral symptoms and was generally well tolerated.

That earlier study called for larger, placebo-controlled research. This new Brazilian trial begins to provide the kind of more rigorous evidence researchers said was needed.

Still, the latest findings should be viewed as promising rather than definitive. A trial involving 26 participants is small, and this particular study was single-blind. As the authors acknowledged, larger double-blind studies with longer follow-up periods are needed to confirm effectiveness, evaluate long-term safety and determine how CBD-based treatments might fit into clinical practice.

Full-Spectrum CBD Is Not the Same as CBD Isolate

Another important detail is that researchers used a full-spectrum, CBD-dominant cannabis oil—not simply purified CBD isolate.

Full-spectrum extracts may contain CBD alongside smaller amounts of other cannabinoids, terpenes and naturally occurring plant compounds. That distinction matters because consumers cannot assume that every commercially available CBD product will match the composition, consistency or dosage used in a clinical study.

Product quality also varies widely. Labels do not always tell the whole story, so consumers should look for transparent ingredient information and reliable independent laboratory testing.

Patients should also speak with a qualified healthcare professional before using CBD, particularly if they take prescription medications or have other medical conditions.

This research does not establish that CBD is a cure for burning mouth syndrome. It also does not mean that people experiencing unexplained mouth pain should treat themselves without first receiving a proper medical or dental evaluation.

Cannabis Research Continues to Challenge Outdated Assumptions

For decades, cannabis policy has too often been shaped by stigma and prohibition rather than science. Studies like this one demonstrate why researchers need the legal freedom, resources and institutional support to investigate cannabis-based medicines carefully.

Not every cannabis study will produce a positive result, and not every cannabinoid will be appropriate for every patient. That is precisely why rigorous clinical research matters.

Patients deserve accurate information. Healthcare professionals deserve reliable evidence. Public policy should make it easier—not harder—to conduct the research necessary to provide both.

At Suncoast NORML, we believe that honest education and evidence-based cannabis policy go hand in hand. When an early clinical trial identifies a potentially useful option for people living with a painful and poorly managed condition, the appropriate response is neither hype nor dismissal.

The appropriate response is more research.

The Bottom Line

A randomized clinical trial involving 26 patients found that daily use of a full-spectrum, CBD-dominant cannabis extract was associated with reduced burning mouth syndrome pain and improved oral health-related quality of life. Researchers reported no adverse events during the study.

The findings are encouraging, but they remain preliminary. Larger double-blind trials and longer follow-up periods will be necessary before researchers can determine the treatment’s long-term safety, ideal dosage and appropriate role in patient care.

Suncoast NORML extends its appreciation to National NORML for bringing attention to this research and for continuing the national organization’s decades-long work of educating the public and reforming America’s marijuana laws.

Suncoast NORML is proud to carry that mission forward in the Tampa Bay region—and proud to share the NORML name, history and tradition established by the national organization.

For more cannabis science, policy news and reform updates, continue following Suncoast NORML and support NORML’s work nationwide.

This article is provided for educational purposes only and should not be considered medical advice. CBD has not been established as an approved treatment for burning mouth syndrome. Anyone experiencing persistent oral pain should consult a qualified medical or dental professional.